Furthermore, soluble CD40L levels have been positively correlated with obesity and metabolic syndrome [37,38], and studies in rodents have shown that vascular inflammation and atherosclerosis could be prevented by CD40 deficiency [39,40]. This evidence concerns the gene CD40 and metabolic syndrome.